학술논문

PBRM1 loss reduces IFN gamma-STAT1 activity and promotes resistance to immunotherapy and antiangiogenic therapy in renal cell carcinoma
Document Type
Journal
Source
CANCER RESEARCH; JUL 2019, 79 13, 2p. Supplement: S
Subject
Language
English
ISSN
15387445